In addition, C. maxima albedo extract exhibited wide ranges of inhibitory properties against enzymes, which are drug targets for the treatment of AD (AChE, BChE, and BACE-1), obesity (lipase), and diabetes (α-glucosidase and α-amylase). Here, BCHE is linked to obesity due to melanocortin 4 receptor deficiency.